Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Response I: Vascular and Cellular

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...

Acute Inflammation III: Local and Systemic Effects

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

p16INK4a as an adjunct test in cervical cytology.

European journal of gynaecological oncology·2016

Same author

Malrotation of the colon with volvulus.

American journal of diseases of children (1911)·2010

Same author

Brain-immune interactions and disease susceptibility.

Molecular psychiatry·2005

Same author

Different approaches to understanding autoimmune rheumatic diseases: the neuroimmunoendocrine system.

Best practice & research. Clinical rheumatology·2004

Same author

Lipopolysaccharide-induced oestrogen receptor regulation in the paraventricular hypothalamic nucleus of lewis and Fischer rats.

Journal of neuroendocrinology·2002

Same author

Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.

Molecular psychiatry·2002

Search research articles

Related Experiment Video

Updated: Jul 29, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Anti-inflammatory cytokines: expression and action in the brain.

L Vitkovic¹, S Maeda, E Sternberg

¹Integrative Neural Immune Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. vitkovic@hotmail.com

Neuroimmunomodulation

|June 5, 2002

Summary

Transforming growth factor-beta(1) (TGF-beta(1)) and interleukin-10 (IL-10) gene expression is altered in brain diseases. These cytokines protect neurons and regulate glial cells, offering therapeutic potential.

More Related Videos

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Published on: February 21, 2025

Related Experiment Videos

Last Updated: Jul 29, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Published on: February 21, 2025

Area of Science:

Neuroscience
Immunology
Molecular Biology

Background:

Transforming growth factor-beta(1) (TGF-beta(1)) and interleukin-10 (IL-10) gene expression patterns are variable in normal brain tissue.
These cytokine expressions are significantly upregulated in numerous central and peripheral nervous system diseases and disorders.
Published literature indicates that both neurons and glial cells produce and respond to TGF-beta(1) and IL-10.

Purpose of the Study:

To elucidate the specific expression patterns of TGF-beta(1) and IL-10 across different neuropathologies.
To understand the neuroprotective and glial-modulating roles of TGF-beta(1) and IL-10, particularly in non-inflammatory contexts.
To explore the potential therapeutic applications of these cytokines by defining their role within neural cytokine networks.

Main Methods:

Review and synthesis of published data on TGF-beta(1) and IL-10 gene expression in neurological conditions.
Analysis of the cellular sources (neurons, glial cells) and targets of these cytokines in the central and peripheral nervous systems.
Examination of the interplay between TGF-beta(1)/IL-10 and other key inflammatory mediators like IL-1 and TNF-alpha.

Main Results:

TGF-beta(1) and IL-10 exhibit distinct expression profiles that vary among different diseases.
These cytokines exert neuroprotective effects and suppress glial cell activation, even in the absence of overt inflammation.
TGF-beta(1) and IL-10 counterbalance the pro-inflammatory actions of IL-1 and TNF-alpha, contributing to neural homeostasis.

Conclusions:

TGF-beta(1) and IL-10 play crucial roles in neural function and disease modulation.
Their 'anti-inflammatory' actions extend to neuroprotection and glial regulation, independent of inflammation.
A deeper understanding of their integration into neural cytokine networks is essential for harnessing their therapeutic potential in neurological disorders.